A cost-utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy

Gl Colombo; S Di Matteo; Ketty Peris; Mc Fargnoli; M Esposito; A Mazzotta; S. Chimenti

A cost-utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy

Gl Colombo, S Di Matteo, Ketty Peris, Mc Fargnoli, M Esposito, A Mazzotta, S. Chimenti

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Abstract

Biologic therapies have proven efficacious for patients with moderate-to-severe psoriasis. However, their economic value compared with standard of care in Italy has not been explored. This study estimates the cost-effectiveness of intermittent therapy with etanercept in patients with moderate-to-severe plaque-type psoriasis in comparison with nonsystemic therapy in Italy.

Lingua originale	English
pagine (da-a)	53-59
Numero di pagine	7
Rivista	ClinicoEconomics and Outcomes Research
Volume	1
Stato di pubblicazione	Pubblicato - 2009

Keywords

Markov model
cost-effectiveness
cost-utility
etanercept
psoriasis

Altri file e collegamenti

Link a IRIS PubliCatt

Cita questo

@article{c4afd8d0460e4af69f64de3e3429de11,

title = "A cost-utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy",

abstract = "Biologic therapies have proven efficacious for patients with moderate-to-severe psoriasis. However, their economic value compared with standard of care in Italy has not been explored. This study estimates the cost-effectiveness of intermittent therapy with etanercept in patients with moderate-to-severe plaque-type psoriasis in comparison with nonsystemic therapy in Italy.",

keywords = "Markov model, cost-effectiveness, cost-utility, etanercept, psoriasis, Markov model, cost-effectiveness, cost-utility, etanercept, psoriasis",

author = "Gl Colombo and {Di Matteo}, S and Ketty Peris and Mc Fargnoli and M Esposito and A Mazzotta and S. Chimenti",

year = "2009",

language = "English",

volume = "1",

pages = "53--59",

journal = "ClinicoEconomics and Outcomes Research",

issn = "1178-6981",

publisher = "Dove Medical Press Ltd",

}

TY - JOUR

T1 - A cost-utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy

AU - Colombo, Gl

AU - Di Matteo, S

AU - Peris, Ketty

AU - Fargnoli, Mc

AU - Esposito, M

AU - Mazzotta, A

AU - Chimenti, S.

PY - 2009

Y1 - 2009

N2 - Biologic therapies have proven efficacious for patients with moderate-to-severe psoriasis. However, their economic value compared with standard of care in Italy has not been explored. This study estimates the cost-effectiveness of intermittent therapy with etanercept in patients with moderate-to-severe plaque-type psoriasis in comparison with nonsystemic therapy in Italy.

AB - Biologic therapies have proven efficacious for patients with moderate-to-severe psoriasis. However, their economic value compared with standard of care in Italy has not been explored. This study estimates the cost-effectiveness of intermittent therapy with etanercept in patients with moderate-to-severe plaque-type psoriasis in comparison with nonsystemic therapy in Italy.

KW - Markov model

KW - cost-effectiveness

KW - cost-utility

KW - etanercept

KW - psoriasis

KW - Markov model

KW - cost-effectiveness

KW - cost-utility

KW - etanercept

KW - psoriasis

UR - http://hdl.handle.net/10807/57495

M3 - Article

SN - 1178-6981

VL - 1

SP - 53

EP - 59

JO - ClinicoEconomics and Outcomes Research

JF - ClinicoEconomics and Outcomes Research

ER -

A cost-utility analysis of etanercept for the treatment of moderate-to-severe psoriasis in Italy

Abstract

Keywords

Altri file e collegamenti

Fingerprint

Cita questo